Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc. (DRUG) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DRUG · as of Jun 8, 2026
Key Statistics
Explore Bright Minds Biosciences Inc. Data
drug stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
The DRUG analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $159.50, representing +144.33% upside from the current price of $65.28.
Competitors & Peers
drug competitorsDRUG
ALT
ANNX
AURA
DMAC
DSGNStock Performance
Full HistoryAbout Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc. is a preclinical biotechnology firm dedicated to creating serotonin-based therapies. Its primary goal is to enhance the well-being of individuals suffering from severe an…
what is bright minds biosciences inc. · drug stock overview · bright minds biosciences inc. company profile · who is bright minds biosciences inc. ceo · drug NASDAQ · bright minds biosciences inc. headquarters · bright minds biosciences inc. business segments
About Stock Overview & Key Data
Bright Minds Biosciences Inc. (DRUG) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 22, 2021. As of the latest trading session, DRUG stock price is $65.28, with a market capitalization of $506.7M. The stock has returned +134.15% over the past 12 months and -16.35% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Bright Minds Biosciences Inc. stock is Buy, with an average 12-month price target of $159.50. In fiscal year 2025, Bright Minds Biosciences Inc. reported revenue of — and net income of -$12.2M. For detailed data — including Bright Minds Biosciences Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Bright Minds Biosciences Inc. (DRUG) stock price is $65.28. The stock is traded on NASDAQ under the ticker symbol DRUG. The 52-week range is $23.18 – $123.75.